Encryption Agility Engineer
Amgen
Encryption Agility Engineer
Amgen
Makes biotech medicines for serious illnesses
Role Name: Specialist Information Security - Encryption Agility Engineer
Job Posting Title: Specialist Information Security - Encryption Agility Engineer
Department Name: Trusted Core Technologies
ABOUT AMGEN
Amgen harnesses the best of biology and technology to fight the world's toughest diseases, and make people's lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Amgen helped establish the biotechnology industry more than 40 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today.
ABOUT THE ROLE
Role Description:
The Specialist Information Security - Encryption Agility Engineer will serve as a senior hands-on engineer for Amgen's enterprise Encryption Agility Service for Post-Quantum Cryptography (PQC) Readiness Preparation. This role supports the Senior Manager Information Security - Encryption Agility Service Lead and the Senior Specialist Information Security - Encryption Agility Team Architect by executing the technical work needed to build and operate Amgen's enterprise cryptographic inventory, discovery workflows, Cryptographic Bill of Materials (CBOM), remediation tracking, and engineering guidance for encryption, cryptography, crypto agility, and post-quantum readiness. The role is expected to be practical, technical, and service-oriented, with the ability to analyze cryptographic findings across applications, cloud, infrastructure, identity, Public Key Infrastructure (PKI), certificates, Key Management Services (KMS), secrets, data protection, Software as a Service (SaaS), and third-party ecosystems.
This position will translate architecture direction into working implementation tasks, data quality rules, dashboards, tool integrations, remediation tickets, secure patterns, developer guidance, and repeatable Standard Operating Procedures (SOPs). The engineer will partner with Digital Identity Access Service (DIAS), PKI and certificate service owners, Application Security, Artificial Intelligence (AI) Security, Enterprise Architecture, cloud, infrastructure, platform, Risk and Compliance, Procurement, Legal, Third Party Risk Management (TPRM), Operational Technology (OT), and vendor teams to help make Amgen's PQC roadmap measurable, actionable, and sustainable.
The role is also expected to identify high-volume, human-intensive Encryption Agility Service processes and design Artificial Intelligence (AI)-enabled orchestration patterns that reduce manual work, improve analysis speed, increase team throughput, and strengthen service consistency. This includes the ability to architect AI agents or coordinated teams of AI agents that support cryptographic inventory analysis, Cryptographic Bill of Materials (CBOM) data quality, remediation tracking, reporting, evidence review, and governance workflows while maintaining human-in-the-loop decision points for risk acceptance, exception handling, production change decisions, and other activities requiring accountable human judgment.
Roles & Responsibilities:
Basic Qualifications and Experience:
Functional Skills:
Must-Have Skills:
Good-to-Have Skills:
Professional Certifications:
Soft Skills:
EQUAL OPPORTUNITY STATEMENT
Amgen is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.
We will ensure that individuals with disabilities are provided with reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request an accommodation.
.Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen